Literature DB >> 1552366

Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans.

W H Ling1, O Hänninen.   

Abstract

We studied the effect on fecal hydrolytic activities of adopting an uncooked extreme vegan diet and readopting a conventional diet. Eighteen subjects were randomly divided into test and control groups. In the test group subjects adopted the uncooked extreme vegan diet for 1 mo and then resumed a conventional diet for a second month. Controls consumed a conventional diet throughout the study. Phenol and p-cresol concentrations in serum and daily output in urine and fecal enzyme activities were measured. The activity of fecal urease significantly decreased (by 66%) as did cholylglycine hydrolase (55%), beta-glucuronidase (33%) and beta-glucosidase (40%) within 1 wk of beginning the vegan diet. The new level remained throughout the period of consuming this diet. Phenol and p-cresol concentrations in serum and daily outputs in urine significantly declined. The fecal enzyme activities returned to normal values within 2 wk of resuming the conventional diet. Concentrations of phenol and p-cresol in serum and daily output in urine had returned to normal after 1 mo of consuming the conventional diet. No changes were observed in the control group during the study. Results suggest that this uncooked extreme vegan diet causes a decrease in bacterial enzymes and certain toxic products that have been implicated in colon cancer risk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552366     DOI: 10.1093/jn/122.4.924

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  16 in total

1.  Effect of substrate composition on intestinal flora.

Authors:  W E Moore
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

2.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  Fatty acid composition of erythrocyte, platelet, and serum lipids in strict vegans.

Authors:  J J Agren; M L Törmälä; M T Nenonen; O O Hänninen
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

4.  Association of fecal microbial diversity and taxonomy with selected enzymatic functions.

Authors:  Roberto Flores; Jianxin Shi; Mitchell H Gail; Pawel Gajer; Jacques Ravel; James J Goedert
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

Review 5.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

Review 6.  The health advantage of a vegan diet: exploring the gut microbiota connection.

Authors:  Marian Glick-Bauer; Ming-Chin Yeh
Journal:  Nutrients       Date:  2014-10-31       Impact factor: 5.717

7.  The intestine and the kidneys: a bad marriage can be hazardous.

Authors:  Raymond Vanholder; Griet Glorieux
Journal:  Clin Kidney J       Date:  2015-02-10

8.  Sensory Characterization of Odors in Used Disposable Absorbent Incontinence Products.

Authors:  Heléne Widén; Susanne Alenljung; Ulla Forsgren-Brusk; Gunnar Hall
Journal:  J Wound Ostomy Continence Nurs       Date:  2017 May/Jun       Impact factor: 1.741

9.  Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.

Authors:  Megan Rossi; Kerenaftali Klein; David W Johnson; Katrina L Campbell
Journal:  Int J Nephrol       Date:  2012-12-19

Review 10.  Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment.

Authors:  Gregory A Plotnikoff
Journal:  Glob Adv Health Med       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.